NantHealth Inc expected to post a loss of 9 cents a share - Earnings Preview

Nanthealth

02/08/2021 22:14

* NantHealth Inc  NH.OQ   NH.O  is expected to show a fall in
quarterly revenue when it reports results on August 5. 
* The Culver City, California-based company is expected to
report   a 5.6% decrease in revenue to $16.598 million from
$17.59 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for NantHealth Inc is for a
loss of 9 cents per share. For the same quarter last year, the
company reported a loss of 7 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for NantHealth Inc
is $3.75​, about 46.7% above​ its last closing price
of $2.00. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.08       -0.07      -0.09     Missed  -20
 Dec. 31 2020  -0.08       -0.08      -0.06     Beat    25
 Sep. 30 2020  -0.07       -0.06      -0.07     Missed  -7.7​
 Jun. 30 2020  -0.06       -0.05      -0.07     Missed  -27.3
 Mar.          -0.06​      -0.06      -0.06     Met     7.7​
 31​ 2020​                                              
 Dec. 31 2019  -0.06       -0.05      -0.04     Beat    27.3​
 Sep. 30 2019  -0.03       -0.03      -0.07     Missed  -100
 Jun. 30 2019  -0.09       -0.09      -0.04     Beat    55.6
 This summary was machine generated August 2 at 21:14 GMT.  All
figures in US dollars unless otherwise stated